Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy

European Journal of Cancer

Volumn 51, Issue 5, 2015, Pages 604-609

  Ohwaki, Kazuhiro ^a,b   Endo, Fumiyasu ^a   Hattori, Kazunori ^a  

^a ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^b TOKYO KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

Abdominal obesity; Antihypertensive agents; Hypertension; Prostate cancer; Prostatectomy; Recurrence

Indexed keywords

ANTIHYPERTENSIVE AGENT; PROSTATE SPECIFIC ANTIGEN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CANCER RECURRENCE; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG USE; FOLLOW UP; GLEASON SCORE; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ADENOCARCINOMA; ADVERSE EFFECTS; BLOOD; BLOOD PRESSURE; CANCER GRADING; CHI SQUARE DISTRIBUTION; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; RADIOGRAPHY; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADENOCARCINOMA; ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; HUMANS; HYPERTENSION; INTRA-ABDOMINAL FAT; KALLIKREINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; OBESITY, ABDOMINAL; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 84924386477     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.01.003     Document Type: Article

References (24)

1. M.N. Simmons, A.J. Stephenson, and E.A. Klein Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy Eur Urol 51 2007 1175 1184
2. C.R. Pound, A.W. Partin, M.A. Eisenberger, D.W. Chan, J.D. Pearson, and P.C. Walsh Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
3. F.M. Jhaveri, C.D. Zippe, E.A. Klein, and P.A. Kupelian Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results Urology 54 1999 884 890
4. J.F. Ward, M.L. Blute, J. Slezak, E.J. Bergstralh, and H. Zincke The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy J Urol 170 2003 1872 1876
5. A.W. Hsing, L.C. Sakoda, and S. Chua Jr. Obesity, metabolic syndrome, and prostate cancer Am J Clin Nutr 86 2007 s843 s857
6. R. Asmar, J.L. Beebe-Dimmer, K. Korgavkar, G.R. Keele, and K.A. Cooney Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy Prostate Cancer Prostatic Dis 16 2013 62 66
7. E.H. Allott, E.M. Masko, and S.J. Freedland Obesity and prostate cancer: weighing the evidence Eur Urol 63 2013 800 809
8. S.J. Freedland, W.J. Aronson, C.J. Kane, J.C. Presti Jr., C.L. Amling, D. Elashoff, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group J Clin Oncol 22 2004 446 453
9. S.J. Freedland, M.K. Terris, J.C. Presti Jr., C.L. Amling, C.J. Kane, B. Trock, et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins J Urol 172 2004 520 524
10. Y. Cao, and J. Ma Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis Cancer Prev Res (Phila) 4 2011 486 501
11. J.M. Post, J.L. Beebe-Dimmer, H. Morgenstern, C. Neslund-Dudas, C.H. Bock, N. Nock, et al. The metabolic syndrome and biochemical recurrence following radical prostatectomy Prostate Cancer 2011 2011 245642
12. J.J. Tomaszewski, Y.F. Chen, M. Bertolet, B.T. Ristau, E. Woldemichael, and J.B. Nelson Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy Urology 81 2013 992 996
13. S.A. Siddiqui, B.A. Inman, S. Sengupta, J.M. Slezak, E.J. Bergstralh, B.C. Leibovich, et al. Obesity and survival after radical prostatectomy: a 10-year prospective cohort study Cancer 107 2006 521 529
14. P. Motamedinia, R. Korets, B.A. Spencer, M.C. Benson, and J.M. McKiernan Body mass index trends and role of obesity in predicting outcome after radical prostatectomy Urology 72 2008 1106 1110
15. J.L. Beebe-Dimmer, R.L. Dunn, A.V. Sarma, J.E. Montie, and K.A. Cooney Features of the metabolic syndrome and prostate cancer in African-American men Cancer 109 2007 875 881
16. P. Tuohimaa, L. Tenkanen, H. Syvälä, S. Lumme, T. Hakulinen, J. Dillner, et al. Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer Cancer Epidemiol Biomarkers Prev 16 2007 302 307
17. J. Hammarsten, and B. Högstedt Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer Blood Press 13 2004 47 55
18. A.W. Partin, and J.E. Oesterling The clinical usefulness of prostate specific antigen: update 1994 J Urol 152 1994 1358 1368
19. L. Sjöström, H. Kvist, A. Cederblad, and U. Tylén Determination of total adipose tissue and body fat in women by computed tomography, 40K, and tritium Am J Physiol 250 1986 E736 E745
20. H. Kvist, B. Chowdhury, L. Sjöström, U. Tylén, and A. Cederblad Adipose tissue volume determination in males by computed tomography and 40K Int J Obesity 12 1988 249 266
21. M.S. Cookson, G. Aus, A.L. Burnett, E.D. Canby-Hagino, A.V. D'Amico, R.R. Dmochowski, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes J Urol 177 2007 540 545
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
23. A.L. Fitzpatrick, J.R. Daling, C.D. Furberg, R.A. Kronmal, and J.L. Weissfeld Hypertension, heart rate, use of antihypertensives, and incident prostate cancer Ann Epidemiol 11 2001 534 542
24. C. Rodriguez, E.J. Jacobs, A. Deka, A.V. Patel, E.B. Bain, M.J. Thun, et al. Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Causes Control 20 2009 671 679